Non-Interventional Study
OtherNon-interventional study
NCT Number: NCT06200116
This study measures the utility of a novel artificial intelligence (AI) algorithm for performing auto-segmentation of computed tomography (CT) scans for radiation therapy planning.
Interested in participating?
Request InfoAll sexes
Observational
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
PRIMARY OBJECTIVE:
I. To measure the observed utility of an AI algorithm for normal segmentation by recording study subjects' observations of its function.
OUTLINE: This is an observational study.
Participants complete surveys about the performance/functionality of the auto-segmentation algorithm on study.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Non-interventional study
Time frame: Baseline
Will be evaluated by question 1 of the end user survey, which evaluates the level of modification to the artificial intelligence generated auto-segmentation structures that was required (no modification, minor modification, or major modification). Auto-segmentation algorithm data will be collected through an electronic data collection form.
Contact information is provided by the study sponsor or research team.
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07285044
Adenocarcinoma, Adnexal Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT07235501
Graft Versus Host Disease, Graft vs Host Disease
Duarte, California, United States
View Trial DetailsNCT06513962
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Birmingham, Alabama, United States
View Trial DetailsNCT06941324
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Ann Arbor, Michigan, United States
View Trial Details